辉瑞血友病B基因疗法Durveqtix获得了欧盟授权

$Sangamo Therapeutics (SGMO.US)$ https://seekingalpha.com/news/4128465-辉瑞血友病B基因疗法Durveqtix获得了欧盟授权?utm_source=futu&utm_medium=referral&feed_item_type=资讯&drsp=1&client_hour_clock=24&clientlang=2